Search Results - "SEGEL, Scott A"

Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes by SEGEL, Scott A, PARAMORE, Deanna S, CRYER, Philip E

“…Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes Scott A. Segel , Deanna S. Paramore and Philip E. Cryer From the Division of…”
Get full text

Immunoglobulin G4 hypophysitis in a 63-year-old woman with no autoimmune history: a case report by Gersey, Zachary C, Rajjoub, Kenan R, Pearce, Thomas M, Segel, Scott A, Gardner, Paul A, Snyderman, Carl H, Wang, Eric W, Zenonos, Georgios A

“…Abstract Background Immunoglobulin-G4-related hypophysitis is a rare inflammatory disease that can present as a tumefactive pituitary lesion mimicking…”
Get full text

Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia by SEGEL, Scott A, FANELLI, Carmine G, DENCE, Carmen S, MARKHAM, Joanne, VIDEEN, Tom O, PARAMORE, Deanna S, POWERS, William J, CRYER, Philip E

“…Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia Scott A. Segel 1 3 4 , Carmine G…”
Get full text

A novel endocrinology-based wellness program to reduce medication expenditures and improve glycemic outcomes by Evans, J. Gary, Sutton, David R, Dajani, Lorraine H, Magee, J. Sample, Silva, Ricardo A, Roura, Miguel F, Wadud, Khurram, Purcell, John A, Travaglini, Stefano, Segel, Scott A, Sultan, Senan, Roffman, Melissa S, Ayad, Salwa S, Borja-Hart, Nancy L, Smith, Steven M

“…Abstract Aims The purpose of this study was to determine the difference in diabetes-related medication expenditures as a result of a 16-week lifestyle…”
Get full text

Defective Glucose Counterregulation in Type 2 Diabetes by SEGEL, SCOTT A, PARAMORE, DEANNA S, CRYER, PHILIP E

Get full text

Blood-to-brain glucose transport, cerebral glocuse metabolis, and cerebral blood flow are not increased after hypoglycemia by Segel, Scott A, Fanelli, Carmine G, Dence, Carmen S, Markham, Joanne, Videen, Tom O, Paramore, Deanna S, Powers, William J, Cryer, Philip E

Get full text

Symptomatic anti-parkinsonian effects of monoamine oxidase-B inhibition: comparison of selegiline and lazabemide by LeWitt, P A, Segel, S A, Mistura, K L, Schork, M A

“…Selegiline (deprenyl) and lazabemide (Ro 19-6327) are inhibitors of monoamine oxidase-B but differ in several other pharmacological properties. We compared…”
Get more information